文献速递泌尿男性生殖肿瘤

高纯度循环肿瘤细胞RNA测序识别与临床结局相关的前列腺癌谱系表型

High-purity CTC RNA sequencing identifies prostate cancer lineage phenotypes prognostic for clinical outcomes.
PubMed 文献 · Cancer Discov · 2025-02-06

研究采用新型循环肿瘤细胞(CTC)分离方法,对117例转移性前列腺癌患者的273份CTC样本进行RNA测序,其中70例患者的146份样本肿瘤纯度与组织活检相当。研究识别出四种CTC转录表型,其中管腔B样表型(持续AR信号和高增殖)及神经内分泌表型患者生存显著短于管腔A样和低增殖表型患者;在前瞻性子研究中,治疗前CTC管腔B样表型与177Lu-PSMA-617早期进展相关。

要点

  • 高纯度CTC RNA测序可识别四种与组织谱系状态对应的CTC转录表型。
  • 管腔B样CTC表型(持续AR信号和高增殖)及神经内分泌CTC表型患者生存显著更短。
  • 前瞻性子研究中,治疗前管腔B样CTC表型与177Lu-PSMA-617早期进展相关。

核心结论

  • 高纯度CTC RNA测序可识别与临床结局相关的前列腺癌谱系表型,管腔B样和神经内分泌CTC表型患者生存显著更短。

研究设计与样本

  • 研究采用新型CTC分离方法,收集117例转移性前列腺癌患者的273份CTC样本进行RNA测序;其中70例患者的146份样本肿瘤纯度与组织活检相当。
  • 另有一项前瞻性子研究评估治疗前CTC表型与177Lu-PSMA-617早期进展的关联。

主要发现

  • 共识别出四种CTC转录表型,与组织中所识别的谱系状态相对应。
  • 管腔B样CTC表型(以持续AR信号和高增殖为特征)及神经内分泌CTC表型患者生存显著短于管腔A样和低增殖表型患者。
  • 在前瞻性子研究中,治疗前CTC管腔B样表型与177Lu-PSMA-617早期进展相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The development of treatment resistance remains universal for patients with metastatic prostate cancer, driven by AR alterations and lineage state transitions. Identifying the evolution of lineage transitions in treatment resistance has been limited by the challenges of collecting serial tissue biopsies on treatment, which can be overcome using blood-based liquid biopsies. Utilizing a novel circulating tumor cell (CTC) isolation approach, we collected 273 CTC samples from 117 patients with metastatic prostate cancer for RNA sequencing. 146 samples from 70 patients had tumor purity comparable to tissue biopsies. We identified four CTC transcriptional phenotypes, mirroring lineage states identified in tissue. Patients with a luminal-B-like CTC phenotype defined by persistent AR signaling and high proliferation, as well as those with a neuroendocrine CTC phenotype, had significantly shorter survival than patients with luminal-A-like and low proliferation phenotypes. In a prospective substudy, pre-treatment CTC luminal-B-like phenotype was associated with early progression on 177Lu-PSMA-617.

来源:Cancer Discov,查看原文。版权归原作者所有。

引用

  1. Sharifi MN, Sperger JM, Taylor AK, et al. High-purity CTC RNA sequencing identifies prostate cancer lineage phenotypes prognostic for clinical outcomes. Cancer Discov. 2025. PMID: 39912912. doi:10.1158/2159-8290.CD-24-1509

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。